Compared to BRAFwt/MSS cancers, BRAFmut/MSS cancers showed significantly more frequent focal deletions at 18q (11/33, 33% Vs 1/18, 6%; p = 0.04) predominantly encompassing 18q21.2 which includes the SMAD2 gene locus. The gene discussed is SMAD2; the disease is cancer.